Neil Hamilton
Overview
Explore the profile of Neil Hamilton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
435
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smith H, Thompson A, Akil M, Alabed S, Charalampopoulos A, Dwivedi K, et al.
J Heart Lung Transplant
. 2024 Sep;
43(10):1629-1639.
PMID: 39260921
Background: There are limited data assessing the spectrum of systemic sclerosis-associated pulmonary hypertension (PH). Methods: Data for 912 systemic sclerosis patients assessed between 2000 and 2020 were retrieved from the...
2.
Lawrie A, Hamilton N, Wood S, Exposto F, Muzwidzwa R, Raiteri L, et al.
Pulm Circ
. 2024 Jul;
14(3):e12399.
PMID: 38979095
We aimed to describe the clinical characteristics, healthcare resource utilization (HCRU) and costs, health-related quality of life (HRQoL), and survival for patients with pulmonary arterial hypertension (PAH), stratified by 1-year...
3.
Varian F, Dick J, Battersby C, Roman S, Ablott J, Watson L, et al.
Pulm Circ
. 2024 Mar;
14(1):e12337.
PMID: 38500737
Approved therapies for the treatment of patients with pulmonary arterial hypertension (PAH) mediate pulmonary vascular vasodilatation by targeting distinct biological pathways. International guidelines recommend that patients with an inadequate response...
4.
Durrington C, Hurdman J, Elliot C, Maclean R, Van Veen J, Saccullo G, et al.
Eur Respir J
. 2024 Feb;
63(3).
PMID: 38302154
Background: Diagnostic rates and risk factors for the subsequent development of chronic thromboembolic pulmonary hypertension (CTEPH) following pulmonary embolism (PE) are not well defined. Methods: Over a 10-year period (2010-2020),...
5.
Kiely D, Hamilton N, Wood S, Durrington C, Exposto F, Muzwidzwa R, et al.
BMJ Open
. 2024 Jan;
14(1):e080068.
PMID: 38176861
Objectives: This study was conducted to evaluate the ability of risk assessment to predict healthcare resource utilisation (HCRU), costs, treatments, health-related quality of life (HRQoL) and survival in patients diagnosed...
6.
Alabed S, Garg P, Alandejani F, Dwivedi K, Maiter A, Karunasaagarar K, et al.
Eur Respir J
. 2023 Jul;
62(2).
PMID: 37414419
Background: Cardiac magnetic resonance (CMR) is the gold standard technique to assess biventricular volumes and function, and is increasingly being considered as an end-point in clinical studies. Currently, with the...
7.
Lawrie A, Hamilton N, Wood S, Exposto F, Muzwidzwa R, Raiteri L, et al.
Pulm Circ
. 2022 Oct;
12(4):e12136.
PMID: 36204241
A retrospective, observational cohort study was conducted to generate real-world evidence in adult patients diagnosed with sarcoidosis-associated pulmonary hypertension (SAPH) at a referral center in England between 2012 and 2019....
8.
Alabed S, Alandejani F, Dwivedi K, Karunasaagarar K, Sharkey M, Garg P, et al.
Radiology
. 2022 Aug;
304(3):E56.
PMID: 35994400
No abstract available.
9.
Alabed S, Alandejani F, Dwivedi K, Karunasaagarar K, Sharkey M, Garg P, et al.
Radiology
. 2022 Jun;
305(1):68-79.
PMID: 35699578
Background Cardiac MRI measurements have diagnostic and prognostic value in the evaluation of cardiopulmonary disease. Artificial intelligence approaches to automate cardiac MRI segmentation are emerging but require clinical testing. Purpose...
10.
Wardle M, Nair A, Saunders S, Armstrong I, Charalampopoulos A, Elliot C, et al.
Pulm Circ
. 2022 May;
12(1):e12019.
PMID: 35506074
Patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (PH) are at increased risk when undergoing anesthesia and major surgery. Data on outcomes for elective orthopedic surgery in patients...